Prior to enrollment in the study, the patient self-administered icatibant (Firazyr®; Takeda) for on-demand treatment of HAE attacks; he also received IV-C1-INH (Berinert®; CSL Behring) in the emergency department as needed. Here, SERPING1 is linked to hereditary angioedema.